Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification and Multicentral Clinical Validation of Plasma Diagnostic Biomarkers for Gastric Cancer Based on Wide-targeted and Targeted Metabolomics

NCT06109805 is registered in ClinicalTrials.gov with Beijing Friendship Hospital as lead sponsor.

NCT NCT06109805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06109805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification and Multicentral Clinical Validation of Plasma Diagnostic Biomarkers for Gastric Cancer Based on Wide-targeted and Targeted Metabolomics
Lead sponsor
Beijing Friendship Hospital
Phase
Observational
Overall status
Completed
Start date
October 20, 2023
Completion date
February 18, 2025
Enrollment
1,706 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer